Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report - Poll - MDSpire

Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report

  • By

  • Ke Li

  • Juanjuan Hu

  • Zhiji Gan

  • Jiao Chen

  • Ye Tian

  • Ruiqing Luo

  • Xueliang Qi

  • July 15, 2026

Share

Original Source(s)

Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report

  • by Ke Li, Juanjuan Hu, Zhiji Gan, Jiao Chen, Ye Tian, Ruiqing Luo, Xueliang Qi

  • July 15, 2026

Related Content

Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics

Mesenchymal stem cell therapy as adjunctive treatment in pediatric patients with severe acquired brain injury: a single-center retrospective case series

Impact of a virtual reality program on the cognitive and psycho-emotional state of seniors with mild cognitive impairment